SCN2A and epilepsy: The results of this study provide a window into the types of complex genetic interactions underlying autism–epilepsy comorbidity, while also identifying Kcna1 as a modifier of ASD susceptibility and Kv1.1 subunits or related networks and pathways as potential therapeutic targets in autism due to Scn2a mutations.